| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2931235 | International Journal of Cardiology | 2010 | 6 Pages |
Abstract
Drug-eluting stents are frequently used in Australia in the high-risk setting of STEMI. While target vessel revascularisation rates were moderate in this high-risk group, there was no increased mortality, reinfarction or stent thrombosis compared to bare-metal stents.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
R. Gurvitch, J. Lefkovits, R.J. Warren, S.J. Duffy, D.J. Clark, D. Eccleston, B.P. Yan, C. Reid, A. Brennan, N. Andrianopoulos, A.E. Ajani,